![Amy McKee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy McKee
Director/Board Member at
BIOCRYST PHARMACEUTICALS, INC.
Net worth: 420 347 $ as of 30/05/2026
Profile
Dr. Amy E.
McKee, MD, is a Senior Vice President-Oncology Regulatory Science at AstraZeneca PLC and an Independent Director at BioCryst Pharmaceuticals, Inc. She is on the Board of Directors at BioCryst Pharmaceuticals, Inc. Dr. McKee was previously employed as a Chief Medical Officer & Head-Oncology Center by PAREXEL International Corp.
and a Deputy Director-Oncology Center of Excellence by US Food & Drug Administration.
She received her undergraduate degree from Middlebury College and a doctorate degree from Tulane University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/06/2026 | 47,177 ( 0.02% ) | 420 347 $ | 30/05/2026 |
Amy McKee active positions
| Companies | Position | Start |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | 19/09/2021 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 31/08/2024 |
Former positions of Amy McKee
| Companies | Position | End |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Chief Tech/Sci/R&D Officer | 31/08/2024 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 31/01/2019 |
Training of Amy McKee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
31
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Middlebury College
 Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Amy McKee
